It has been shown that PPARγ increases the expression of Foxp3+ Tregs, suggesting that during IBD this could lead to greater numbers of FoxP3+ Tregs in the colon, where it is needed to suppress the actions of the activated effector T cells. Here, FOXP3 is linked to inflammatory bowel disease.